{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Brazil Healthcare Plans news", "home_page_url": "https://sharemaestro.com/newsreel/br/healthcare/healthcare-plans/", "feed_url": "https://sharemaestro.com/newsreel/br/healthcare/healthcare-plans/feed.json", "description": "Latest Healthcare Plans company headlines from Brazil, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:a70cae582178023f97c17d47a0839120926b87bdd694780e1f452e8d69dbcac0", "url": "https://finance.yahoo.com/healthcare/articles/mark-cuban-says-401-k-111500193.html", "external_url": "https://finance.yahoo.com/healthcare/articles/mark-cuban-says-401-k-111500193.html", "title": "Mark Cuban says your 401(k) is \u2018part of the cost of health care problem.\u2019 Do you dump Big Insurance and own your values?", "content_text": "Photo by Nicola Gell / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. If your retirement savings are invested in a broad index fund, Mark Cuban says you may be helping America's largest health insurers put profits ahead of patients. \"If you own shares in a fund that owns any of the biggest insurance carriers, you are part of the cost of health care problem in this country,\" the billionaire entrepreneur wrote on X (1). Must Read Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 \u2014 6 ways to b", "date_published": "2026-08-14T11:15:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "H1UM34", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}, {"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:eff5922e101371e66c6fa7e287bc65b5cf721f7fc28b7dab3b5aa6a295c6bcc3", "url": "https://finance.yahoo.com/markets/stocks/articles/zacks-com-featured-highlights-biomarin-093800634.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/zacks-com-featured-highlights-biomarin-093800634.html", "title": "Zacks.com featured highlights include BioMarin Pharmaceutical, Invesco, Centene Corporation, Hewlett Packard Enterprise and Gibraltar Industries", "content_text": "For Immediate Release Chicago, IL \u2013 August 14, 2026 \u2013 Stocks in this week's article are BioMarin Pharmaceutical BMRN, Invesco IVZ, Centene Corporation CNC, Hewlett Packard Enterprise HPE and Gibraltar Industries ROCK. 5 Undervalued Price-to-Book Stocks Worth Buying in August There are several different ways to find value stocks. Among these, the most popular are the price-to-earnings ratio (P/E) and the price-to-sales ratio (P/S). However, investors often overlook the price-to-book ratio (P/B ratio), which, though used less often, is also an easy-to-use valuation tool for identifying low-price", "date_published": "2026-08-14T09:38:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:00080bf9420de03300de7c149c296f3f345081ac0dcee7187c6ee511e8f63e22", "url": "https://finance.yahoo.com/markets/stocks/articles/centene-cnc-stock-still-looks-091638310.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/centene-cnc-stock-still-looks-091638310.html", "title": "Centene (CNC) Stock Still Looks Like A Bargain As Shares Jumped 145%", "content_text": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Centene stock has surged over the past year, yet the current checks still suggest it leans on the cheap side, so investors are weighing how much of the recent optimism is already reflected in the price. Centene has returned 145.2% over the past year, which puts a spotlight on whether the recent share price strength is outpacing the underlying fundamentals. Raised expectations for future revenue and earnings, together with a plan to redeem part of its debt, can support the case for", "date_published": "2026-08-14T09:16:38+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:d5b221d008e784284f5506267720554628003b8a8b6031e7a850813ad41e63d8", "url": "https://finance.yahoo.com/healthcare/articles/sixty-compton-california-students-selected-181600514.html", "external_url": "https://finance.yahoo.com/healthcare/articles/sixty-compton-california-students-selected-181600514.html", "title": "Sixty Compton, California Students to be Selected for Leadership and Health Advocacy Training, Powered by Health Net's $412,000 Investment", "content_text": "The company's investment in The Los Angeles Trust for Children's Health will help students build leadership skills, learn to support their peers and connect to local health care services LOS ANGELES, Aug. 11, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), announced a $412,000 grant to The Los Angeles Trust for Children's Health to expand its Wellness Youth Advocate (WYA) program into Compton Unified School District. The investment will help launch the program at Compton High School, Doming", "date_published": "2026-08-13T18:16:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:0b0fb9490ab43a14a6f259c15ca65616328960edddf47dcbe17e6d04df9ccb3e", "url": "https://finance.yahoo.com/healthcare/articles/heres-why-pediatrix-medical-smart-155300567.html", "external_url": "https://finance.yahoo.com/healthcare/articles/heres-why-pediatrix-medical-smart-155300567.html", "title": "Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio", "content_text": "Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including obstetrics, maternal-fetal medicine and neonatology, complemented by multiple pediatric subspecialties. The company has gained 23.9% in the year-to-date period, outperforming the industry's 1.2% growth. MD \u2014 with a market cap of $2.2 billion \u2014is well-poised for growth, benefiting from stronger cash collections, a favorable payer mix and higher patient acuity in neonatology. Strategic acquisitions are adding further support to revenue and earnings growt", "date_published": "2026-08-13T15:53:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Deals and strategy", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:ecd0d53289060f7914c53e120efc8e0a0a0a8e97dbd074319d2b81bfd733fdcc", "url": "https://finance.yahoo.com/healthcare/articles/carolina-complete-health-supports-young-154000860.html", "external_url": "https://finance.yahoo.com/healthcare/articles/carolina-complete-health-supports-young-154000860.html", "title": "Carolina Complete Health Supports Young Leaders Through AMEXCAN Summer Camp", "content_text": "Sponsorship helped 24 children from coastal North Carolina participate in educational, cultural and leadership-building activities CHARLOTTE, N.C., Aug. 13, 2026 /PRNewswire/ -- Carolina Complete Health, a subsidiary of the Centene Corporation (NYSE: CNC), sponsored the AMEXCAN Summer Camp, helping provide 24 children from coastal North Carolina with a summer experience centered on learning, leadership and personal growth.Carolina Complete Health Throughout the program, participants took part in educational workshops, cultural activities, leadership development and recreational programming des", "date_published": "2026-08-13T15:40:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:8731f7effa586440d1d4919b715b969e8607c86f0ca67737b1e8547b3489afb6", "url": "https://seekingalpha.com/news/4632398-unitedhealth-faces-shareholder-suit-accusing-corporate-governance-failures?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4632398-unitedhealth-faces-shareholder-suit-accusing-corporate-governance-failures?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "UnitedHealth faces shareholder suit accusing corporate governance failures", "content_text": "[UnitedHealthcare headquarters in Minnetonka, Minnesota, USA] JHVEPhoto/iStock Editorial via Getty Images UnitedHealth Group (UNH [https://seekingalpha.com/symbol/UNH]) is facing an amended shareholder lawsuit that accuses the insurer of knowing about serious governance issues and doing little to ensure compliance, leading to significant losses in stock value. The suit was filed in a Minnesota federal court by the Employees\u2019 Retirement System of the State of Rhode Island and L\u00e4nsf\u00f6rs\u00e4kringar Fondf\u00f6rvaltning AB, a Swedish asset manager. Plaintiffs blame the board and senior company officers. \"O", "date_published": "2026-08-13T14:18:07+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Capital return", "UNHH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}]}}, {"id": "source:9d32db924ee34a6fd0c1a4bad9032b1acac67011e96847aee0aa81afd2b0fc08", "url": "https://finance.yahoo.com/healthcare/articles/humana-improve-caregiver-retention-healthstream-141700367.html", "external_url": "https://finance.yahoo.com/healthcare/articles/humana-improve-caregiver-retention-healthstream-141700367.html", "title": "Can Humana Improve Caregiver Retention With HealthStream Deal?", "content_text": "Humana Inc.'s HUM Medicaid managed care plan, Humana Healthy Horizons, is teaming up with HealthStream in Indiana to strengthen the state's home-care workforce. Under the initiative, Humana is sponsoring 1,000 Home Health Aide scholarships, helping remove financial barriers for people entering the caregiving field. The program uses HealthStream's Career Network to reach rural and underserved communities, where worker shortages can restrict access to home-based care. Humana is also deploying HealthStream's CoachUp Care platform, predictive analytics and training tools to help providers recruit ", "date_published": "2026-08-13T14:17:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Deals and strategy", "H1UM34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}]}}, {"id": "source:c9f8b0bb43fdc75af27a72e2a94fb69b2b914b52e2eba9e72edcb333236b4303", "url": "https://finance.yahoo.com/healthcare/articles/mhs-serves-announces-recipients-over-133000474.html", "external_url": "https://finance.yahoo.com/healthcare/articles/mhs-serves-announces-recipients-over-133000474.html", "title": "MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment", "content_text": "INDIANAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for 30 years and a Centene (NYSE: CNC) company, is proud to announce the recipients of the MHS Serves Workforce Support Program, a new statewide funding opportunity in partnership with Indiana Minority Health Coalition (IMHC) and Black Onyx Management, designed to strengthen workforce development programs that help Medicaid members prepare for employment, increase their income and build long-term economic stability.MHS The program will provide fund", "date_published": "2026-08-13T13:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Deals and strategy", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:c7625b0b19766561851dad85127678768ff68611e9ab773237c6ed514a1ff9ba", "url": "https://finance.yahoo.com/markets/stocks/articles/5-undervalued-price-book-stocks-132500956.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/5-undervalued-price-book-stocks-132500956.html", "title": "5 Undervalued Price-to-Book Stocks Worth Buying in August", "content_text": "There are several different ways to find value stocks. Among these, the most popular are the price-to-earnings ratio (P/E) and the price-to-sales ratio (P/S). However, investors often overlook the price-to-book ratio (P/B ratio), which, though used less often, is also an easy-to-use valuation tool for identifying low-priced stocks with great returns. The P/B ratio is calculated as below: P/B ratio = market capitalization/book value of equity This metric can help identify attractively priced stocks with upside potential. Some such stocks are BioMarin Pharmaceutical BMRN, Invesco IVZ, Centene Co", "date_published": "2026-08-13T13:25:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:0aba62d8ad07022d11d75e4d8c72c0e2861d387133c8d1bf6b381f9623e0249d", "url": "https://finance.yahoo.com/markets/stocks/articles/best-growth-stocks-buy-august-073100167.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/best-growth-stocks-buy-august-073100167.html", "title": "Best Growth Stocks to Buy for August 13th", "content_text": "Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 13: Schneider National, Inc. SNDR : This provider of truckload, intermodal, and logistics services a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.3% over the last 60 days. Schneider National, Inc. Price and ConsensusSchneider National, Inc. Price and Consensus Schneider National, Inc. price-consensus-chart | Schneider National, Inc. Quote Schneider National has a PEG ratio of 0.80 compared with 1.41 for the industry. The com", "date_published": "2026-08-13T07:31:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:86c2e4e61e3237ea57f1fabd547f1e4c9e0803b3bfe6a8ef49034fd43b00027f", "url": "https://finance.yahoo.com/healthcare/articles/unhs-lower-medical-costs-sustain-183300996.html", "external_url": "https://finance.yahoo.com/healthcare/articles/unhs-lower-medical-costs-sustain-183300996.html", "title": "Can UNH's Lower Medical Costs Sustain the Earnings Recovery?", "content_text": "UnitedHealth Group Incorporated's UNH second-quarter results show that its earnings performance is improving. The medical care ratio (MCR) fell to 86.7% from 89.4% a year ago, meaning the company spent less of its premium revenues on medical care and retained more for profits. This helped operating earnings rise 55%. UNH also raised its 2026 adjusted EPS guidance, reflecting confidence in its earnings recovery. The trend is encouraging, particularly in Medicare. Medical costs are running below UNH's original expectations, aided by better benefit planning, care management and changes in provider networks. OptumHealth is also making progress as it focuses more on value-based care and controls unnecessary medical spending. These trends suggest that the company's cost-control efforts are beginning to show results. Still, the 86.7% MCR may not fully reflect UNH's underlying medical-cost trend. The quarter included $860 million of favorable prior-period medical development. At the same time, commercial medical costs are increasing at a rate exceeding 11%, caused by higher provider billing and coding intensity and specialty drug costs. This could keep pressure on commercial margins for longer. UNH's earnings rebound looks encouraging, but its durability remains the key issue. The company's 2027 pricing and benefit decisions will be an important test. If the company can maintain pricing growth in line with rising medical costs, margin expansion could drive further earnings growth. Otherwise, sustained medical-cost pressure may constrain future earnings growth. How Are UNH's Peers Positioned? UnitedHealth isn't alone; peers from the Medical space, including Elevance Health, Inc. ELV and CVS Health Corporation CVS, are also navigating changing medical cost trends. Elevance Health's second-quarter benefit expense ratio was 89.7%, up 80 basis points year over year, mainly due to higher medical costs in its government businesses. Still, ELV raised its 2026 adjusted EPS guidance to at least $27. This shows Elevance is using pricing and cost controls to protect margins. CVS Health is showing encouraging cost-control trends. Its Aetna business benefited from lower medical costs in the second quarter, helping the company deliver strong earnings beat and raise its 2026 adjusted EPS guidance to $7.90-$8.10. However, CVS faces uncertainty heading into 2027 due to ongoing PBM and 340B-related pressures. UNH'sPrice Performance, Valuation & Estimates Shares of UnitedHealth have risen 47.9% in the past 12 months compared with the industry's 41% growth. Story Continues Zacks Investment Research Image Source: Zacks Investment Research From a valuation standpoint, UNH trades at a forward price-to-earnings ratio of 18.83X compared with the industry average of 16.48X. UNH carries a Value Scoreof B.Zacks Investment Research Image Source: Zacks Investment Research The Zacks Consensus Estimate for UnitedHealth's 2026 earnings is pegged at $19.69 per share, implying a 20.4% increase from the year-ago period's level.Zacks Investment Research Image Source: Zacks Investment Research UNH currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report Elevance Health, Inc. (ELV) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments", "date_published": "2026-08-12T18:33:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "UNHH34", "CVSH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}, {"symbol": "CVSH34", "name": "CVS Health Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/fe6a3fb9-00e5-4867-a043-816b06543553/"}]}}, {"id": "source:62cb161741ffba71f7ca7b8d7663cdb4f5fadb510745501c351a85b3971c529a", "url": "https://finance.yahoo.com/technology/articles/sandbox-vr-continues-expand-first-173100410.html", "external_url": "https://finance.yahoo.com/technology/articles/sandbox-vr-continues-expand-first-173100410.html", "title": "Sandbox VR Continues to Expand with its First North Carolina Venue in Winston-Salem, Opening August 14", "content_text": "Sandbox VR brings the 'best virtual reality experience on the planet' to Downtown Winston-Salem WINSTON-SALEM, N.C., Aug. 12, 2026 /PRNewswire/ -- Sandbox VR, the world's premier venue for virtual reality experiences, is set to open its first North Carolina location on August 14, 2026. Sandbox VR is working with Madison Bennett Corporation to bring the highly immersive experience to Downtown Winston-Salem. Guests can take advantage of a special limited-time presale offer of 30% off through August 13 at https://sandboxvr.com/winstonsalem. With nearly 150,000 players monthly, Sandbox VR is rapidly growing its global footprint with thriving corporate-owned locations and a robust franchising program. Sandbox VR's 6,000 square foot venue in the former CVS building will feature a bar, a private party room, and four VR rooms where groups of up to six guests suit up with headsets, haptic vests, and motion sensors for full-body immersion. This technology allows players to see and physically interact with one another, creating the feeling of living inside the action together. The premium experience extends from arrival to exit, with personalized highlight videos allowing guests to relive and share their adventures. \"We're incredibly excited to bring Sandbox VR to downtown Winston-Salem,\" said Arthur Hengler, Sandbox VR Winston-Salem Franchise Owner. \"There's so much happening downtown, and we think Sandbox VR is a great addition to the restaurants, nightlife and entertainment that already make it such a fun place to spend time. We can't wait to welcome local families, students, professionals and visitors to come experience it for themselves.\" Sandbox VR operates both corporate-owned locations and a robust franchise program, and recently hit $300M in lifetime sales while scaling to more than 90 global locations across five continents and 12 countries since launching in 2016. The company is redefining group entertainment with immersive experiences that transform any outing into lasting memories. Built by a team of veteran developers from EA, Sony, and Ubisoft, Sandbox VR delivers full-body immersion through exclusive content and original experiences, including the recently launched Stranger Things: Catalyst, in collaboration with Netflix, and the new Age of Dinosaurs experience in partnership with the Natural History Museum of London and leading dinosaur experts. Sandbox VR provides an unparalleled entertainment experience with over 250,000 five-star reviews from guests worldwide. With over 6 million lifetime tickets sold across five continents, the company has established itself as the global leader in location-based virtual reality. Sandbox VR is backed by Andreessen Horowitz, Alibaba Entrepreneurs Fund, Gobi Partners, Craft, and Stanford University, along with individuals such as Kevin Durant, Justin Timberlake, and Katy Perry. Story Continues To learn more about Sandbox VR, visit https://sandboxvr.com/winstonsalem. ABOUT SANDBOX VR Sandbox VR is the world's premier destination for location-based virtual reality experiences. Operating across 90+ venues around the globe through a robust franchise and corporate-owned model, Sandbox VR attracts nearly 150,000 guests each month. Sandbox VR provides guests the opportunity to step out of everyday reality into unforgettable adventures through exhilarating, group-play immersive experiences. Using a proprietary full-body VR platform, the company develops original and licensed content, including exclusive experiences like Stranger Things: Catalyst and Squid Game Virtuals in collaboration with Netflix, and the Sandbox VR original Deadwood series. With over 6 million tickets sold worldwide, Sandbox VR has become the leader in immersive entertainment, combining premium technology with emotionally engaging storytelling. Recognized as one of Fast Company's Most Innovative Companies and a two-time honoree on the Inc. 5000 list of America's fastest-growing private companies, Sandbox VR is headquartered", "date_published": "2026-08-12T17:31:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "CVSH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "CVSH34", "name": "CVS Health Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/fe6a3fb9-00e5-4867-a043-816b06543553/"}]}}, {"id": "source:27e6ea333d13ddafb3b24f0306bcff3b1bf2d9c8043259937837808fc729b11e", "url": "https://finance.yahoo.com/healthcare/articles/mark-cuban-urges-investors-pressure-133105638.html", "external_url": "https://finance.yahoo.com/healthcare/articles/mark-cuban-urges-investors-pressure-133105638.html", "title": "Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: \u2018You Can Make a Difference\u2019", "content_text": "Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mark Cuban on Monday urged investors to pressure major U.S. health insurers to address healthcare costs, calling on funds that hold shares in the industry to consider divesting their positions unless insurers change their practices. Shareholders in the Spotlight The billionaire entrepreneur said investors who own funds with stakes in major insurance carriers are \"part of the cost of healthcare problem,\" adding that insurers keep share prices ahead of patients and mislead people to increase prof", "date_published": "2026-08-12T13:31:05+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "UNHH34", "H1UM34", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}, {"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}, {"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:c8d21d29bd5f5906943f1b323537450852f230acaa97eda0c070ec611eab8f9c", "url": "https://finance.yahoo.com/healthcare/articles/study-cvs-caremark-employee-benefit-130000183.html", "external_url": "https://finance.yahoo.com/healthcare/articles/study-cvs-caremark-employee-benefit-130000183.html", "title": "New study from CVS Caremark and Employee Benefit News shows how employers rely on their pharmacy benefit manager to create sustainable pharmacy solutions", "content_text": "Key opportunities include: managing GLP-1s, encouraging biosimilar substitution and employing technology to simplify and personalize the member experience WOONSOCKET, R.I., Aug. 12, 2026 /PRNewswire/ -- CVS Caremark, part of CVS Health\u00ae (NYSE: CVS), today announced the findings of a survey conducted in partnership with Employee Benefit News that reveals why employers are increasingly relying on their pharmacy benefit manager (PBM) partners to use their expertise, scale and purchasing power to help them manage their top concern: battling rising drug prices and maintaining access to quality care.CVS Health (PRNewsFoto/CVS Health) This year's The State of Pharmacy Management Survey findings show HR decision makers and executive leaders are focused on navigating the rising price of prescription drugs, managing access to expensive treatments such as GLP-1s, and encouraging the use of more cost-effective biosimilars. Key Findings 91% of employers are concerned about the high prices of medication for employees 88% of employers see PBMs as especially well positioned to reduce prescription drug costs for their businesses 64% say PBMs have the greatest opportunity to improve access to affordable specialty medications \"This data reveals the urgency behind employers' need for PBM partners who can address cost, first and foremost,\" said Ed DeVaney, President, CVS Caremark. \"There's a clear opportunity to help employers navigate the evolving pharmacy benefits landscape while driving sustainable benefits for clients and members.\" Opportunity for employers to encourage greater use of biosimilars The survey findings also illustrate that biosimilars represent one of the largest untapped opportunities for employers to reduce drug costs in the U.S. health care market, offering clinically equivalent therapies to improve affordability and enhance access without compromising safety or efficacy. Today, only about half of employers (49%) are encouraging biosimilar substitution while another 40% are actively considering or exploring it. With just 12% of employers reporting that they are educating employees about the cost savings potential, this study illustrates a significant opportunity for employers to do more to both create better awareness and understanding of the benefits of biosimilars and help their members access them. CVS Caremark has been an industry leader in promoting biosimilar adoption. Since April 2024, biosimilar formulary strategy has helped CVS Caremark clients and members realize more than $3.3 billion in gross savings related to Humira\u00ae (adalimumab), and the company is committed to expanding the use of low-cost biosimilars across multiple therapeutic categories. Story Continues On July 1, 2026, CVS Caremark transitioned from Stelara\u00ae (ustekinumab) on its most common commercial template formularies to prefer lower-cost, interchangeable biosimilar alternatives \u2014 Pyzchiva\u00ae and Yesintek\u00ae. Most members will pay $0 out-of-pocket for their therapy. Employers are planning for emerging areas of pharmacy spend, including GLP-1 weight management Weight management has moved into the benefits mainstream, becoming a core component of modern benefits strategy. Seventy-seven percent of employers say the high cost of GLP-1 coverage is a concern \u2014 with 80% having either already limited GLP-1 coverage for weight loss or considering limits. CVS Caremark is focused on improving affordability and access to GLP-1s by increasing access to GLP-1 weight management medications this year with expanded coverage options. In addition to negotiating lower prices with drug manufacturers, CVS Caremark works with clients to leverage the right GLP-1 management strategies for each employee population, including utilization management, personalized clinical and nutrition support and more. The lifestyle-first approach of the CVS Weight Management\u2122 program has driven sustainable weight loss results for members and cost savings for plan sponsors. Clients who adopted the pr", "date_published": "2026-08-12T13:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "CVSH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "CVSH34", "name": "CVS Health Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/fe6a3fb9-00e5-4867-a043-816b06543553/"}]}}, {"id": "source:6c4eb822e99c1572f035db88a7469db636932b9cfc5b2cf0013c7d743319ba4b", "url": "https://finance.yahoo.com/markets/stocks/articles/canada-nickel-announces-non-brokered-124600783.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/canada-nickel-announces-non-brokered-124600783.html", "title": "Canada Nickel Announces Non-Brokered Private Placement for Gross Proceeds of C$15 Million", "content_text": "Canada Nickel logo /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Aug. 12, 2026 /CNW/ -- Canada Nickel Company Inc. (\"Canada Nickel\" or the \"Company\") (TSXV:CNC) is pleased to announce that it intends to complete a non-brokered private placement for gross proceeds of C$15,000,000 (the \"Offering\"). The Offering will consist of 10,000,000 units of the Company (each, a \"Unit\") to be issued at a price of C$1.50 per Unit. Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant (each who", "date_published": "2026-08-12T12:46:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:9b25b1e02e37ab34b9a2b1c83feefcdbf52e0b4a8f01c136537530027cc43776", "url": "https://seekingalpha.com/news/4631378-unitedhealth-declares-2_32-dividend?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4631378-unitedhealth-declares-2_32-dividend?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "UnitedHealth declares $2.32 dividend", "content_text": "* UnitedHealth (UNH [https://seekingalpha.com/symbol/UNH]) declares $2.32/share quarterly dividend [https://seekingalpha.com/pr/20616162-unitedhealth-group-board-authorizes-payment-of-quarterly-dividend], in line with previous. * Forward yield [https://seekingalpha.com/symbol/UNH/dividends/yield?source=news_bullet] 2.31% * Payable Sept. 22; for shareholders of record Sept. 14; ex-div Sept. 14. * See UNH Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/UNH/dividends?source=news_bullet] MORE ON UNITEDHEALTH * UnitedHealth's Medicare Recovery Is Accelerating An", "date_published": "2026-08-12T11:04:45+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Capital return", "UNHH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}]}}, {"id": "source:6bf06bec00ed503097133882937fa22ce7793e92f7ec4ffd2e0982d222d148ad", "url": "https://finance.yahoo.com/healthcare/articles/unitedhealth-group-board-authorizes-payment-110000732.html", "external_url": "https://finance.yahoo.com/healthcare/articles/unitedhealth-group-board-authorizes-payment-110000732.html", "title": "UnitedHealth Group Board Authorizes Payment of Quarterly Dividend", "content_text": "August 12, 2026--(BUSINESS WIRE)--The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.32 per share, to be paid on September 22, 2026, to all shareholders of record of UNH common stock as of the close of business September 14, 2026. About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a healthcare and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the healthcare experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20260812374098/en/ Contacts Investors: investor_relations@uhg.com Media: uhgmedia@uhg.com View Comments", "date_published": "2026-08-12T11:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "UNHH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}]}}, {"id": "source:27572bf45f4c1715fa8e4b25526eec7815d0b826e9eaedc671420692319eb1b9", "url": "https://finance.yahoo.com/markets/stocks/articles/1-profitable-stock-impressive-fundamentals-021322550.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/1-profitable-stock-impressive-fundamentals-021322550.html", "title": "1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down", "content_text": "1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies \u2014 as Jeff Bezos said, \"Your margin is my opportunity\". Not all profitable companies are created equal, and that's why we built StockStory - to help you find the ones that truly shine bright. That said, here is one profitable company that balances growth and profitability and two that may struggle to keep up. Two Stocks to Sell: Pool (POOL) Trailing 12-Month GAAP Operating Margin: 10.8% Founded in 1993 and headquartered in Louisiana, Pool (NASDAQ:POOL) is one of the largest wholesale distributors of swimming pool supplies, equipment, and related leisure products. Why Do We Think POOL Will Underperform? Sales trends were unexciting over the last five years as its 2.2% annual growth was below the typical consumer discretionary company Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital Diminishing returns on capital from an already low starting point show that neither management's prior nor current bets are going as planned At $205.34 per share, Pool trades at 17.7x forward P/E. Check out our free in-depth research report to learn more about why POOL doesn't pass our bar. CVS Health (CVS) Trailing 12-Month GAAP Operating Margin: 2% With over 9,000 retail pharmacy locations serving as neighborhood health destinations across America, CVS Health (NYSE:CVS) operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance through its Aetna subsidiary. Why Is CVS Not Exciting? Scale is a double-edged sword because it limits the company's growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 6.9% for the last two years Estimated sales growth of 1.7% for the next 12 months implies demand will slow from its two-year trend Annual earnings per share growth of 1.1% underperformed its revenue over the last five years, showing its incremental sales were less profitable CVS Health's stock price of $95.56 implies a valuation ratio of 11.9x forward P/E. If you're considering CVS for your portfolio, see our FREE research report to learn more. One Stock to Buy: Nova (NVMI) Trailing 12-Month GAAP Operating Margin: 29% Headquartered in Israel, Nova (NASDAQ:NVMI) is a provider of quality control systems used in semiconductor manufacturing. Why Should You Buy NVMI? Impressive 23.4% annual revenue growth over the last five years indicates it's winning market share this cycle Disciplined cost controls and effective management resulted in a strong two-year operating margin of 29%, and its operating leverage amplified its profits over the last five years Earnings per share grew by 27.4% annually over the last five years and trumped its peers Story Continues Nova is trading at $398.25 per share, or 30.6x forward P/E. Is now the right time to buy? Find out in our full research report, it's free. Stocks We Like Even More WHILE YOU'RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses. But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week \u2014 FREE. Get Our Top 9 Market-Beating Stocks for Free HERE. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today. View Comments", "date_published": "2026-08-12T02:13:22+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "CVSH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "CVSH34", "name": "CVS Health Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/fe6a3fb9-00e5-4867-a043-816b06543553/"}]}}, {"id": "source:27a4eb5c716fa78a21efaecc02e8e47d0cc4a928f6a65be7f9ddca85f028bcfa", "url": "https://finance.yahoo.com/healthcare/articles/health-net-providing-special-assistance-180900059.html", "external_url": "https://finance.yahoo.com/healthcare/articles/health-net-providing-special-assistance-180900059.html", "title": "Health Net Providing Special Assistance to Members and Providers Affected by Gann Fire in Calaveras County", "content_text": "SACRAMENTO, Calif., Aug. 11, 2026 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Calaveras County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), is taking immediate action to support those affected by the Gann Fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time.Health Net of California Member Prescription Information During a declared State of Emergency, impacted members have two options to se", "date_published": "2026-08-11T18:09:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:5c3d6b75c03cbfb9be5a2df4bf63a926bdd7735c3070325723b4ddbd67c2c17b", "url": "https://finance.yahoo.com/markets/stocks/articles/boeing-upgraded-under-armour-downgraded-133858700.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/boeing-upgraded-under-armour-downgraded-133858700.html", "title": "Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls", "content_text": "Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Argus upgraded Boeing (BA) to Buy from Hold with a $265 price target. The firm believes the company has \"superior\" long-term prospects due to its leading presence in the growing commercial aerospace industry. Truist upgraded Best Buy(BBY) to Buy from Hold with a price target of $95, up from $81. The firm's credit card reads are", "date_published": "2026-08-11T13:38:58+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:72eae7cf1509a8034d3a982cd2f0972b620f3e53cdd0a78d16724aecde474424", "url": "https://finance.yahoo.com/markets/stocks/articles/2-top-ranked-high-flying-121300588.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/2-top-ranked-high-flying-121300588.html", "title": "2 Top-Ranked High-Flying Non-AI Bigwigs to Buy at Lucrative Valuation", "content_text": "The astonishing rally of the artificial intelligence (AI) trade has been showing no signs of abatement even after more than three and a half years. In 2026, the AI trade maintained its northward journey albeit at a slow pace. This year, several non-AI stocks are flourishing along with AI-powered stocks. We have selected two such stocks with a top Zacks Rank that are currently trading at a lucrative valuation. Investment in these stocks should be fruitful for the rest of 2026. These stocks are: Centene Corp. CNC and Franklin Resources Inc. BEN. Each of our picks currently sports a Zacks Rank #1", "date_published": "2026-08-11T12:13:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:bc1d2370d6cdb0bac1c6677055796a6ba127ea75bf1ac807a8771c05b4f90178", "url": "https://finance.yahoo.com/healthcare/articles/humana-healthy-horizons-indiana-collaborates-120000802.html", "external_url": "https://finance.yahoo.com/healthcare/articles/humana-healthy-horizons-indiana-collaborates-120000802.html", "title": "Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce", "content_text": "Certification Scholarships and Innovative Retention Program Address Critical Health Need INDIANAPOLIS, August 11, 2026--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana, Humana's Medicaid managed care plan, is collaborating with HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, to improve the lives of Hoosiers who rely on home-based healthcare. To help address persistent caregiver shortages and high turnover, Humana is sponsoring 1,000 Home Health Aide (HHA) scholarships, removing financial and access barriers for individuals see", "date_published": "2026-08-11T12:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "H1UM34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}]}}, {"id": "source:10482eb88540a33ed2b05580c14c4e2ec35304d513bae96c1c0706d2ae66dcba", "url": "https://finance.yahoo.com/healthcare/articles/elizabeth-warren-says-unitedhealth-cvs-223113505.html", "external_url": "https://finance.yahoo.com/healthcare/articles/elizabeth-warren-says-unitedhealth-cvs-223113505.html", "title": "Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare\u2014Now She Wants to Break Up the Vertical Integration", "content_text": "Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Sen. Elizabeth Warren (D-Mass) has criticized the vertical integration in the U.S. healthcare system, arguing that it leads to higher costs for patients and increased profits for large corporations. Warren took to X on Sunday and used UnitedHealth Group Inc. as an example of a company that controls multiple aspects of healthcare, including insurance, pharmacies, and providers. She argued that this consolidation leads to higher costs for patients while increasing corporate profits. She explained this consolidation, highlighting how entities like UnitedHealthcare and Optum Inc. link multiple parts of the care chain from insurance to specialty pharmacy services. Warren added that the same thing also applies to CVS Health Corp. Don't Miss: A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge \u2014 and why Still Learning the Market? These 50 Must-Know Terms Can Help You Catch Up Fast \"That's not right \u2014 and I have a bill to stop it,\" said Warren as she backed the bipartisan Patients Before Monopolies Act (S. 4509), which she co-sponsored with Sen. Josh Hawley (R-MO). The bill was reintroduced in May after first launching it in 2024. The bill would ban common ownership of insurers and pharmacies and require companies to divest such holdings within a year to boost competition and lower drug prices. Supporters of the bill said that, over time, the conglomerates behind the three major PBMs, UnitedHealth Group, CVS Health and Cigna Group, have come to exercise \"control over every link in the prescription drug delivery chain\" by both reimbursing pharmacies and owning or operating them. In America, one health care company can own: Your doctor Your pharmacy Your insurance AND the middleman between your pharmacy and insurance. That means more profits for giant companies and higher costs for you. That's not right \u2014 and I have a bill to stop it. pic.twitter.com/AkrTo9Zyso \u2014 Elizabeth Warren (@SenWarren) August 9, 2026 Trending: Avoid the #1 Investing Mistake: How Your 'Safe' Holdings Could Be Costing You Big Time Warren, Cuban Push For Healthcare Reform Warren's criticism of the healthcare system comes at a time when the cost of healthcare is a major concern for many Americans. Previously, the Senator proposed a wealth tax that could provide children with access to healthcare. She has also been critical of the narrative surrounding self-made billionaires and pushed her ultra-millionaire wealth tax proposal to fund the healthcare program. Story Continues Warren's comments also align with those of billionaire entrepreneur and Costplusdrugs.com CEO Mark Cuban, who argued that companies may be overspending on healthcare due to a lack of visibility into complex insurance contracts. Cuban accused vertically integrated healthcare companies of exploiting employers' reluctance to change, while brokers and consultants may also discourage switches because of the added work. See Also: Skip the Regrets: The Essential Retirement Tips Experts Wish Everyone Knew Earlier. Hence, he urged CEOs to use AI tools such as ChatGPT, Claude, Grok or Gemini to review healthcare contracts and uncover potential issues. UnitedHealth Group recently reported better-than-expected second-quarter results and raised its full-year 2026 earnings guidance, citing progress in simplifying operations, improving affordability and leveraging technology to enhance healthcare services. Image via Shutterstock Read Next: Think you're saving enough for your kids? You might be dangerously off \u2014 see why Building Wealth Across More Than Just the Market Building a resilient portfolio means thinking beyond a single asset or market trend. Economic cycles shift, sectors rise and fall, and no one investment performs well in every environment. That's why many investors look to diversify with platforms that provide access to real estate, fixed-income opportunit", "date_published": "2026-08-10T22:31:13+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "UNHH34", "CVSH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}, {"symbol": "CVSH34", "name": "CVS Health Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/fe6a3fb9-00e5-4867-a043-816b06543553/"}]}}, {"id": "source:74d8c048d53fee1f508789805f085e9659ce947ca66ac6fca58611cc0bf4c0cf", "url": "https://finance.yahoo.com/healthcare/articles/james-p-holland-join-humana-181500209.html", "external_url": "https://finance.yahoo.com/healthcare/articles/james-p-holland-join-humana-181500209.html", "title": "James P. Holland to Join Humana as Medicaid President", "content_text": "LOUISVILLE, Ky., August 10, 2026--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that James \"J.P.\" Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company's growing Medicaid business, which currently serves more than 1.6 million members in 11 states. Holland will report to Aaron Martin, President of Insurance. \"Medicaid is an important part of how we deliver on Humana's purpose, helping some of the most vulnerable populations access the care and support they need to achieve their best health,\" ", "date_published": "2026-08-10T18:15:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "H1UM34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}]}}, {"id": "source:62964ff10c3ed54c87a9142d2806a661521a4657e0b3ebb8533be5644385ecd3", "url": "https://finance.yahoo.com/markets/stocks/articles/3-p-500-stocks-approach-215722192.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/3-p-500-stocks-approach-215722192.html", "title": "3 S&P 500 Stocks We Approach with Caution", "content_text": "3 S&P 500 Stocks We Approach with Caution While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds. Picking the right S&P 500 stocks requires more than just buying big names, and that's where StockStory comes in. That said, here are three S&P 500 stocks that don't make the cut and some better choices instead. Dollar General (DG) Market Cap: $28 billion Appealing to the budget-conscious consumer, Dollar General (NYSE:DG) is a discount retailer that ", "date_published": "2026-08-09T21:57:22+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:e7ae2cc8c43ec1a74dfa900ede01b1494e0950924f767ed82a88307623ef1edd", "url": "https://finance.yahoo.com/healthcare/articles/unitedhealth-unh-commits-4m-tennessee-181302253.html", "external_url": "https://finance.yahoo.com/healthcare/articles/unitedhealth-unh-commits-4m-tennessee-181302253.html", "title": "UnitedHealth (UNH) Commits $4M to Tennessee Health Hub Expansion", "content_text": "On July 29, UnitedHealth Group (NYSE:UNH) announced a $4 million commitment, funded through the United Health Foundation, to expand the University of Tennessee Health Sciences' health hub network from 5 locations to 13 across the state by the end of 2027, a buildout expected to reach 200,000 Tennessee residents. It's a modest sum for a company this size, but it lands as UnitedHealth works to repair a business that fell apart just a year earlier.UnitedHealth (UNH) Commits $4M to Tennessee Health Hub Expansion Bull Case: Margins Are Turning The Other Way The repair is showing up in the numbers. UnitedHealth's medical care ratio, the share of premiums spent on claims, hit 88.9% in 2025, up from 85.5% in 2024, and operating earnings collapsed from $32 billion to $19 billion as a result. That ratio has since started reversing: it came in at 86.7% in the second quarter, below the 88.5% analysts expected, and management is now guiding to 88% for the full year while aiming to beat it. Second-quarter revenue of $112 billion topped the $110.9 billion analysts projected, and adjusted earnings per share of $6.38 came in well above the $4.90 consensus estimate. UnitedHealth followed that quarter by raising its full-year adjusted EPS guidance to a range of $19.50 to $20, up from its prior forecast of $18.25. The company has also credited restructuring, including exiting unprofitable contracts, and new use of AI to speed up processes. UnitedHealth's revenue has grown 150% over the past 10 years, a run one analysis tied to healthcare spending rising faster than the economy. The stock has climbed nearly 50% over the past year as the turnaround has taken hold. Bear Case: Not Everyone Is Convinced Yet Not every signal points the same way. Berkshire Hathaway bought UnitedHealth stock at an average price around $380 in the second quarter of 2025 and exited the position in the first quarter of 2026 at less than $300, one of the conglomerate's rare recent losses. On a trailing basis, the stock still isn't cheap: at a market cap of $380 billion against trailing net income of $14.9 billion, UnitedHealth carries a trailing price-to-earnings ratio of 25.5, a multiple that assumes the margin recovery continues rather than stalls. One analysis put shares at 23 times estimated future earnings and noted the stock would need to climb roughly another 19% to revisit the $500 level it hasn't traded at since early last year, a bar that leaves little room for the medical care ratio to disappoint the way it did in 2025. What The Numbers Say Now UnitedHealth trades at a forward price-to-earnings ratio of 20.58 as of August 7, a discount to its 25.5 trailing multiple, and a sign the market expects the medical care ratio recovery to continue. Short interest sits at a modest 2.13% of the float, suggesting limited organized betting against the turnaround. The hedge fund count tied to the stock fell from 145 to 130 quarter over quarter, a pullback that runs counter to the stock's rebound. Story Continues A Recovery Still Being Tested UnitedHealth's Tennessee expansion is a small piece of a much larger story: a company trying to prove that 2025's earnings collapse was a pricing problem it has since fixed, not a permanent shift in its cost structure. The second-quarter beat, the raised guidance, and the medical care ratio's drop to 86.7% all support that repair story. But Berkshire's exit at a loss, a trailing P/E still above 25, and a stock priced around 23 times future earnings show the market isn't taking the recovery for granted. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on thebest short-term AI stock. READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to I", "date_published": "2026-08-09T18:13:02+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "UNHH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}]}}, {"id": "source:c1d0d4cc90204981456cc5ec86a17f9ad92bf1540e117451cc9c3bcedf7f0be9", "url": "https://finance.yahoo.com/markets/stocks/articles/cigna-ci-stock-still-looks-071657743.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/cigna-ci-stock-still-looks-071657743.html", "title": "Cigna (CI) Stock Still Looks Cheap Following Raised 2026 Outlook", "content_text": "Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Cigna Group stock has delivered a 47.1% total return over the past 5 years, yet current valuation checks still lean toward the shares looking inexpensive rather than fully priced in. In light of recent earnings news and a steady long term track record, investors are weighing whether the recent price of US$282.49 already reflects this progress. Over 5 years, a 47.1% return suggests Cigna Group has rewarded patient shareholders while still inviting a close", "date_published": "2026-08-09T07:16:57+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1IC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1IC34", "name": "The Cigna Group", "sentiment_url": "https://sharemaestro.com/sentiment/d3e6dbc5-fab2-4937-8340-dd7a3b4498a3/"}]}}, {"id": "source:197b95de83905aa67ed0ffd180615f60d1850df84c8d86093cd4c843c8cdfc94", "url": "https://finance.yahoo.com/healthcare/articles/unitedhealth-group-unh-leans-optum-061430711.html", "external_url": "https://finance.yahoo.com/healthcare/articles/unitedhealth-group-unh-leans-optum-061430711.html", "title": "UnitedHealth Group (UNH) Leans On Optum And Medicare Advantage, Is The Stock Already Pricey?", "content_text": "Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. UnitedHealth Group (UNH) is back in focus after fresh attention on its Medicare Advantage and Optum Health businesses, which are helping offset pressure in commercial insurance and shaping how investors interpret the stock's recent moves. See our latest analysis for UnitedHealth Group. Over the past year, UnitedHealth Group's stock has combined a 21.01% year to date share price return with a 66.60% 1 year total shareholder return. The recent 1 month share price return of 4.13% and 7 day share price return of 1.77% suggest some momentum has cooled despite continued focus on Medicare Advantage, Optum Health and sector wide defensive interest. If you are looking beyond UnitedHealth Group and want to see where capital is flowing across the sector, it is a good time to scan for other healthcare names benefiting from AI driven care models using the 43 healthcare AI stocks. For UnitedHealth Group, that mix of Medicare Advantage strength, Optum Health growth and commercial strain leaves one key issue hanging: Is the recent move mostly about the business itself or a swing in sentiment that valuation now needs to test? Most Popular Narrative: 3.1% Overvalued UnitedHealth Group last closed at $407.08, slightly above the narrative fair value of $395. This frames the current share price as modestly rich versus that storyline. Our thesis centers on the fact that the market is discounting the massive value of Optum (Insight, Health, and Rx). While the insurance arm (UnitedHealthcare) is undergoing a painful but necessary \"right-sizing\", shedding ~1.4M members to prioritize margins, Optum continues to scale. By buying UNH at a 13x-15x Forward P/E, investors are essentially acquiring the world's most powerful healthcare data ecosystem at a \"legacy utility\" multiple. Read the complete narrative. Curious what sits behind that Optum centric thesis for UnitedHealth Group? The narrative leans heavily on future cash generation, margin repair and a specific long term earnings profile. The full breakdown explains how those moving pieces relate to a fair value close to $395. Result: Fair Value of $395 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, investors also need to watch for tougher regulatory action on Medicare Advantage and any slowdown in Optum execution that could challenge this UnitedHealth Group narrative. Story Continues Find out about the key risks to this UnitedHealth Group narrative. Another View on UnitedHealth Group's Valuation The user generated narrative concludes that UnitedHealth Group looks 3.1% overvalued at a fair value of $395, yet the SWS DCF model points in the opposite direction. On that view, the stock at $407.08 is trading well below an estimated future cash flow value of $892.98, which frames it as heavily undervalued. The gap between a modest premium to narrative fair value and a large discount to the SWS DCF estimate raises a simple question for investors: Is the market better at pricing UnitedHealth Group off near term earnings and margins, or are long term cash flows being underappreciated? Look into how the SWS DCF model arrives at its fair value.UNH Discounted Cash Flow as at Aug 2026 Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UnitedHealth Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps With sentiment on UnitedHealth Group split between opportunity and concern, it makes sense to move quickly and review the full picture for yourself. To weigh the trade off between its pote", "date_published": "2026-08-09T06:14:30+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "UNHH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UNHH34", "name": "UnitedHealth Group Incorporated", "sentiment_url": "https://sharemaestro.com/sentiment/7b1a93f9-0786-484b-b650-7f6471178f49/"}]}}, {"id": "source:071fc048bb087357cbd70bcfc279001ba9b921731926dcabcae37c98c0dd3401", "url": "https://finance.yahoo.com/healthcare/articles/cigna-group-ci-reports-q2-032339445.html", "external_url": "https://finance.yahoo.com/healthcare/articles/cigna-group-ci-reports-q2-032339445.html", "title": "Cigna Group (CI) Reports Q2 Earnings And Buybacks, Is It Trading At A Discount?", "content_text": "Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Q2 earnings and buybacks put Cigna Group in focus Cigna Group (CI) is back on investors' radar after reporting its second quarter 2026 results, alongside an update on a long running share repurchase program dating back to 2018. See our latest analysis for Cigna Group. Cigna Group's latest earnings and long running buyback program have come alongside mixed share price momentum. The stock is up 2.63% on the day and has a modes", "date_published": "2026-08-09T03:23:39+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1IC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1IC34", "name": "The Cigna Group", "sentiment_url": "https://sharemaestro.com/sentiment/d3e6dbc5-fab2-4937-8340-dd7a3b4498a3/"}]}}, {"id": "source:8cf97c64a6cb0d688f65f5caf962e8e3c0fa52c805047674bf1dd2e18c8494bc", "url": "https://finance.yahoo.com/healthcare/articles/humana-hum-5-8-cutting-221304238.html", "external_url": "https://finance.yahoo.com/healthcare/articles/humana-hum-5-8-cutting-221304238.html", "title": "Humana (HUM) Is Up 5.8% After Cutting 2026 EPS Outlook Amid Strong Q2 And Buybacks", "content_text": "In late July 2026, Humana reported higher second-quarter revenue of US$40,867 million and net income of US$694 million, while also confirming completion of a US$276.13 million share repurchase program initiated in February 2024 and announcing two new board appointments, Paul Smith and Frederick Crawford. Despite stronger quarterly results and governance additions, Humana lowered its full-year 2026 GAAP EPS guidance to at least US$6.52 from at least US$8.36, signaling a more cautious outlook on profitability. We'll now examine how Humana's reduced full-year earnings guidance influences its inve", "date_published": "2026-08-07T22:13:04+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "H1UM34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}]}}, {"id": "source:969a4ecceb94fa810b77c2fada45c3189da594a4d2f7c5eaaf9be04cbd983f56", "url": "https://finance.yahoo.com/small-business/articles/leading-women-run-companies-shaping-175800459.html", "external_url": "https://finance.yahoo.com/small-business/articles/leading-women-run-companies-shaping-175800459.html", "title": "Leading Women-Run Companies Shaping the Future of Business", "content_text": "An updated edition of the June 17, 2026 article. Corporate leadership is evolving as more women assume top executive roles at publicly traded companies. This transition is increasingly backed by strong business performance, with many women-led organizations delivering innovation, operational excellence and consistent shareholder value across diverse industries. Far beyond a shift in representation, these leaders are driving disciplined execution, prudent capital allocation and long-term strategic growth, helping their companies strengthen competitive positioning and build more resilient, susta", "date_published": "2026-08-07T17:58:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:0ba49fcc9f4a0e9afa9fdea7a2531bf573f3939f743eda61b19ea0e0e9200c04", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE92WWVtejdOSENUQjQzVGJqY2hoR0IyRkppejdwWmZhd2hWeHFOS0J3c2xiQ0c5VzJLLU5ieURzb3hoUVlLRWV3Vk93SXRWRXZlRnp5OGstcEpDVFpLZ3pRUXpCSWNhUEE2?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE92WWVtejdOSENUQjQzVGJqY2hoR0IyRkppejdwWmZhd2hWeHFOS0J3c2xiQ0c5VzJLLU5ieURzb3hoUVlLRWV3Vk93SXRWRXZlRnp5OGstcEpDVFpLZ3pRUXpCSWNhUEE2?oc=5", "title": "Proje\u00e7\u00f5es de Resultados: Humana Inc (HUM) \u2014 LPA e Crescimento de Receita", "content_text": "Proje\u00e7\u00f5es de Resultados: Humana Inc (HUM) \u2014 LPA e Crescimento de Receita", "date_published": "2026-08-06T07:00:00+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "H1UM34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}]}}, {"id": "source:ac75227a9f559c73c376beff6b0ac2f6c0e527d22c9a91b2e32aecfdd1bd987e", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOUm9mWDJpYmo0Z3JxRU0xUy1yVllibmJ3WmVKRWxIQ0ZkVVBhNGFxNVVobFpydU81cGpNTTZXalRoWm9mRDdNTHhkclFFQXlDOWt6WFRZalFlSnJHT05HNHBzeUZDNTJPNUJXeVN4Z21yUXVUdG9JbWVxLXd4dTMzUDVYd1hCbHVxSGhQYg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOUm9mWDJpYmo0Z3JxRU0xUy1yVllibmJ3WmVKRWxIQ0ZkVVBhNGFxNVVobFpydU81cGpNTTZXalRoWm9mRDdNTHhkclFFQXlDOWt6WFRZalFlSnJHT05HNHBzeUZDNTJPNUJXeVN4Z21yUXVUdG9JbWVxLXd4dTMzUDVYd1hCbHVxSGhQYg?oc=5", "title": "Centene (C1NC34) eleva proje\u00e7\u00e3o de receita para at\u00e9 US$ 197,5 bi ap\u00f3s 2\u00ba trimestre forte", "content_text": "Centene (C1NC34) eleva proje\u00e7\u00e3o de receita para at\u00e9 US$ 197,5 bi ap\u00f3s 2\u00ba trimestre forte", "date_published": "2026-07-28T14:36:22+00:00", "authors": [{"name": "ADVFN"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:613856939d10b4983209a86c1b0b4faaffcf33f1e952ab6de3af0c077751cccd", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9qb1NTLV9kZVRIelI0cEkwc2VrMW9Bb1ZnQjIyOEhQNzI5VHNIc1o5YThnaEhRdWwxdzJZNnV0emFGQ3VoRHNiUW5pa0QzQzRkUTR6X3gtOHMzdm9waXRjYW8xRDhSS1dSU0Q1eTA0NmM?oc=5", "external_url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9qb1NTLV9kZVRIelI0cEkwc2VrMW9Bb1ZnQjIyOEhQNzI5VHNIc1o5YThnaEhRdWwxdzJZNnV0emFGQ3VoRHNiUW5pa0QzQzRkUTR6X3gtOHMzdm9waXRjYW8xRDhSS1dSU0Q1eTA0NmM?oc=5", "title": "Not\u00edcias CVS Health Corporation - CVS | A\u00e7\u00f5es New York Stock Exchange | ADVFN Brasil", "content_text": "Not\u00edcias CVS Health Corporation - CVS | A\u00e7\u00f5es New York Stock Exchange | ADVFN Brasil", "date_published": "2026-07-25T20:46:02+00:00", "authors": [{"name": "ADVFN"}], "tags": ["Market update", "CVSH34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CVSH34", "name": "CVS Health Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/fe6a3fb9-00e5-4867-a043-816b06543553/"}]}}, {"id": "source:7c1552a0d57ecb708321d7f84109af05d031bebfc4ced7d173e0a27ffc286ae3", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5xVDRoeGZsWTdhRmpQU3FsdElHYS1uWm13WmtvVFpMaExmOWtjXzNwS1pDNG1yQjA4WTdwd2tacUR6SVBodUlZc3g4bDh4TkN0Q1B4TTU5djV3eU1RdkVWU0toMUNYbWI4X3dCc0NCY0hOQ0R3Ty15WGllelJlRWs?oc=5", "external_url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5xVDRoeGZsWTdhRmpQU3FsdElHYS1uWm13WmtvVFpMaExmOWtjXzNwS1pDNG1yQjA4WTdwd2tacUR6SVBodUlZc3g4bDh4TkN0Q1B4TTU5djV3eU1RdkVWU0toMUNYbWI4X3dCc0NCY0hOQ0R3Ty15WGllelJlRWs?oc=5", "title": "A\u00e7\u00f5es da Centene disparam ap\u00f3s os resultados do 3T superarem as estimativas e as proje\u00e7\u00f5es serem revisadas para cima", "content_text": "A\u00e7\u00f5es da Centene disparam ap\u00f3s os resultados do 3T superarem as estimativas e as proje\u00e7\u00f5es serem revisadas para cima", "date_published": "2025-10-29T07:00:00+00:00", "authors": [{"name": "ADVFN"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}, {"id": "source:a8b7668f231fdf52a70b387ce3c2ac478d1b09507df887e158ab217df9ffadfc", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5GXzcySDJxdndOaS1vbHJUZVpNaUJjM0l6NFBfN2ZTNDlMQWZsck53cTg4ejFRcWRKQWZ0bDVhMUdkZnM3QUlCTTBHb0V2TEg4?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5GXzcySDJxdndOaS1vbHJUZVpNaUJjM0l6NFBfN2ZTNDlMQWZsck53cTg4ejFRcWRKQWZ0bDVhMUdkZnM3QUlCTTBHb0V2TEg4?oc=5", "title": "Stock Humana - Stock HUM - Resultados, Dividendos, Cota\u00e7\u00e3o e Indicadores", "content_text": "Stock Humana - Stock HUM - Resultados, Dividendos, Cota\u00e7\u00e3o e Indicadores", "date_published": "2021-05-12T16:08:51+00:00", "authors": [{"name": "Investidor10"}], "tags": ["Market update", "H1UM34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "H1UM34", "name": "Humana Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/613d0721-0fef-48a7-98ce-b96ef5fd3c67/"}]}}, {"id": "source:8c5bbea53509af17e69f68bd904947a9a82ee09dc7b1ef64bb9e3f5fd5a9ad4a", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE84SFJVZE01eU9xc0FaOTZ4YjlGSWZRMWNiMktOOWdhblZpV3djNHltTUhUM3g2enpJMW5fMjJBaHhtZnZDZ2xMTTk5TVo1ZlBJ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE84SFJVZE01eU9xc0FaOTZ4YjlGSWZRMWNiMktOOWdhblZpV3djNHltTUhUM3g2enpJMW5fMjJBaHhtZnZDZ2xMTTk5TVo1ZlBJ?oc=5", "title": "Stock Centene - Stock CNC - Resultados, Dividendos, Cota\u00e7\u00e3o e Indicadores", "content_text": "Stock Centene - Stock CNC - Resultados, Dividendos, Cota\u00e7\u00e3o e Indicadores", "date_published": "2021-04-29T22:05:40+00:00", "authors": [{"name": "Investidor10"}], "tags": ["Market update", "C1NC34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "C1NC34", "name": "Centene Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/a2b56ab8-95c4-45fe-9335-33da1f94e69f/"}]}}]}